Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Watch

Early Replication Fragile Sites May Underlie Gene Rearrangements

DOI: 10.1158/2159-8290.CD-RW2013-026 Published March 2013
  • Article
  • Info & Metrics
Loading
  • Major finding: Replication stress can induce spontaneous breakage of early replication fragile sites (ERFS).

  • Concept: ERFSs are enriched at transcriptionally active regions, repetitive elements, and CpG islands.

  • Impact: ERFSs may contribute to recurrent genomic aberrations in B-cell lymphomas and other cancers.

DNA replication stress caused by oncogene activation or replication fork stalling can induce spontaneous double-strand breaks, particularly at genomic loci known to be inherently unstable, such as late-replicating common fragile sites (CFS). However, in yeast, replication fork collapse can also preferentially affect early-replicating genomic regions, prompting Barlow and colleagues to investigate whether fragility at early-replicating sites can similarly contribute to mammalian genomic instability using activated murine B lymphocytes, which are particularly prone to genomic instability due to their rapid proliferation and DNA damage–dependent immunoglobulin gene rearrangement. Potential loci were found by treating cells synchronized in early S phase with hydroxyurea, an inhibitor of DNA replication, and identifying regions of newly synthesized DNA commonly bound by DNA repair proteins and replication protein A, which binds single-stranded DNA at stalled replication forks. These loci, termed early replication fragile sites (ERFS), were distinct from known CFSs, prone to DNA breakage, and enriched at repetitive elements, GC-rich DNA, and transcriptionally active regions. Of note, some of the most fragile ERFSs were within genes involved in recurrent translocations in lymphomas, suggesting that the inherent instability of this class of fragile sites may contribute to human disease. To evaluate this possibility, the murine ERFS coordinates were mapped to syntenic regions of the human genome and compared with copy number abnormalities observed in patients with diffuse large B-cell lymphoma (DLBCL). Strikingly, 51.6% of DLBCL copy number changes overlapped with syntenic ERFS regions, and ERFSs were over 80% more likely to be deleted or amplified in DLBCL than CFSs. An additional analysis of genes homozygously deleted in cancer genomes revealed that approximately 40% fall within ERFSs. These findings suggest that ERFSs may represent a source of DNA breaks that lead to common genomic rearrangements observed in human cancer.

Barlow JH, Faryabi RB, Callén E, Wong N, Malhowski A, Chen HT, et al. Identification of early replicating fragile sites that contribute to genome stability. Cell 2013 Jan 24 [Epub ahead of print].

  • ©2013 American Association for Cancer Research.
View Abstract
PreviousNext
Back to top
Cancer Discovery: 3 (3)
March 2013
Volume 3, Issue 3
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Early Replication Fragile Sites May Underlie Gene Rearrangements
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Early Replication Fragile Sites May Underlie Gene Rearrangements
Cancer Discov March 1 2013 (3) (3) OF11; DOI: 10.1158/2159-8290.CD-RW2013-026

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Early Replication Fragile Sites May Underlie Gene Rearrangements
Cancer Discov March 1 2013 (3) (3) OF11; DOI: 10.1158/2159-8290.CD-RW2013-026
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • Epstein–Barr Virus–Induced Antitumor Immune Response May Be Harnessable
  • FBXO44 Silences Repetitive Elements during DNA Replication in Cancer
  • Cryo-EM Structures Reveal Mechanism of Anticancer MCT1 Inhibitors
Show more Research Watch

Genomic Instability

  • BCL9L Dysfunction Promotes Aneuploidy Tolerance in Colon Tumors
  • FAN1 Acts as a Tumor Suppressor Preventing Genomic Instability
  • The Fanconi Anemia Pathway Resolves R-Loops to Prevent Genomic Instability
Show more Genomic Instability
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement